EspeRare Foundation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia (NCT04980638) | EspeRare Foundation | 2022-04-26 |
| Rimeporide in Patients With Duchenne Muscular Dystrophy (NCT02710591) | EspeRare Foundation | 2016-03-01 |
Track EspeRare Foundation automatically
Every clearance here is in the API, with alerts when new ones post.